BIOMAT Database Logo BIOMAT Database Logo

Autogenous ascitic infusion in the management of the cirrhotic surgical patient. 1963

R E LEMPKE, and G C KAISER, and R D KING, and H KING

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D010361 Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clients,Client,Patient
D005122 Exudates and Transudates Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS. Transudates,Exudates,Transudates and Exudates,Exudate,Transudate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D019468 Disease Management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596) Disease Managements,Management, Disease,Managements, Disease

Related Publications

R E LEMPKE, and G C KAISER, and R D KING, and H KING
Autogenous ascitic fluid infusion for cirrhotic ascites.
February 1982, Journal of the Indian Medical Association,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
Intravenous infusion of autogenous ascitic fluid in a cirrhotic patient with an umbilical hernia.
April 1970, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
Clinical experience with autogenous ascitic fluid infusion for cirrhotic ascites.
August 1977, The American surgeon,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
Intravenous infusion of dialyzed, autogenous, ascitic fluid in the management of cirrhotic ascites: a preliminary report of favorable results in six patients.
April 1960, Cleveland Clinic quarterly,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
Intractable ascites: treatment by continuous autogenous ascitic infusion.
January 1974, Review of surgery,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
[Infusion of autogenous ascitic fluid in the therapy of liver cirrhosis].
January 1969, Minerva gastroenterologica,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
[Autogenous intravenous infusion of ascitic fluid in patients with liver cirrhosis].
January 1973, Minerva medica,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
Treatment of cirrhotic ascites by perfusion of autogenous ascitic fluid. A provisional report.
November 1966, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
Continuous reinfusion of ascitic fluid in a cirrhotic patient.
March 1978, The Journal of the American Osteopathic Association,
R E LEMPKE, and G C KAISER, and R D KING, and H KING
[Study of the transperitoneal passage of cefoxitin in the ascitic cirrhotic patient].
January 1979, Medecine & chirurgie digestives,
Copied contents to your clipboard!